Status:

COMPLETED

Low-Density Lipoprotein (LDL) Apheresis Using H.E.L.P. Therapy

Lead Sponsor:

B. Braun Medical Inc.

Conditions:

Familial Hypercholesterolemia

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The objectives of this post-surveillance study are to continue to evaluate the safety and effectiveness of the H.E.L.P. System. The safety and effectiveness will be assessed by evaluating the occurren...

Detailed Description

H.E.L.P. therapy is indicated for use in treating patients with familial hypercholesterolemia (FH) who have undergone six months of optimal diet and drug therapy and whose LDL-C level remains \> 300 m...

Eligibility Criteria

Inclusion

  • Adequate venous access
  • Laboratory values:
  • Hematocrit 30% or greater
  • platelet count between 100,000 and 1,000,000/ml
  • Premenopausal women must be surgically sterilized or be on oral contraceptive therapy and have a negative pregnancy test at the onset of treatment with H.E.L.P.
  • Patients have familial hypercholesterolemia and have undergone at least 6 months optimal diet and drug therapy and fit group A, B, or C

Exclusion

  • Presence of any of the following conditions:
  • untreated hypothyroidism
  • decompensated congestive heart failure
  • major arrhythmia
  • uncontrolled diabetes mellitus
  • any malignancy
  • disorders associated with excessive bleeding (e.g., peptic ulcer and hemophilia)
  • established or suspected intracranial disease which might cause intracranial bleeding if the patient is anticoagulated
  • any other medical disorders which lead the treating physician to believe that H.E.L.P. treatment would not be in the best interest of the patient
  • current treatment with anticoagulants
  • diastolic BP \> 100 mmHg recorded in two occasions at least 24 hours apart.
  • patients under 18 years of age
  • positive test for Hepatitis \[Type A (IgM) or B\] antigen, Hepatitis C antibody, or HIV (or diagnosis of AIDS)

Key Trial Info

Start Date :

December 1 1999

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2009

Estimated Enrollment :

113 Patients enrolled

Trial Details

Trial ID

NCT00916643

Start Date

December 1 1999

End Date

September 1 2009

Last Update

April 2 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Low-Density Lipoprotein (LDL) Apheresis Using H.E.L.P. Therapy | DecenTrialz